We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

209 hedge funds and large institutions have $1.08B invested in Adaptive Biotechnologies in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 88 increasing their positions, 58 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

289% more call options, than puts

Call options by funds: $1.62M | Put options by funds: $417K

52% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 58

5.66% more ownership

Funds ownership: 88.71% → 94.37% (+5.7%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 221 → 209 (-12)

25% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 40

38% less capital invested

Capital invested by funds: $1.74B → $1.08B (-$657M)

Holders
209
Holders Change
-12
Holders Change %
-5.43%
% of All Funds
3.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
88
Reduced
58
Closed
40
Calls
$1.62M
Puts
$417K
Net Calls
+$1.21M
Net Calls Change
+$2.11M

Top Buyers

1
BWLSA
Blue Water Life Science Advisors
California
+$27.4M
2
BlackRock
BlackRock
New York
+$26.9M
3
AIM
ARK Investment Management
Florida
+$9.35M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$7.4M
5
Principal Financial Group
Principal Financial Group
Iowa
+$6.02M

Top Sellers

1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$17.9M
2
CC
Casdin Capital
New York
-$13.9M
3
TCM
TimesSquare Capital Management
New York
-$10.9M
4
Ameriprise
Ameriprise
Minnesota
-$9M
5
TM
Tiger Management
New York
-$8.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
101
Avenir Corporation
Virginia
$438K +$221K +25,100 +87%
Commonwealth Equity Services
102
Commonwealth Equity Services
Massachusetts
$424K -$12.2K -1,390 -3%
AIG
103
American International Group
New York
$422K +$442K +50,218 +2,556%
GAM
104
Gotham Asset Management
New York
$422K +$459K +52,206 New
SG Americas Securities
105
SG Americas Securities
New York
$410K +$224K +25,439 +101%
Two Sigma Advisers
106
Two Sigma Advisers
New York
$375K +$302K +34,300 +283%
MIC
107
Maxi Investments CY
Cyprus
$370K – – –
EMG
108
ETF Managers Group
New Jersey
$369K +$17.5K +1,988 +5%
HSBC Holdings
109
HSBC Holdings
United Kingdom
$358K +$140K +15,919 +54%
LPL Financial
110
LPL Financial
California
$357K -$290K -33,008 -43%
AIA
111
Avalon Investment & Advisory
Texas
$353K +$178K +20,257 +87%
VOYA Investment Management
112
VOYA Investment Management
Georgia
$335K -$67.3K -7,651 -16%
Mirae Asset Global Investments
113
Mirae Asset Global Investments
South Korea
$326K +$355K +40,329 New
DADC
114
D.A. Davidson & Co
Montana
$325K +$135K +15,370 +62%
BNP Paribas Financial Markets
115
BNP Paribas Financial Markets
France
$307K +$259K +29,483 +347%
ECM
116
ExodusPoint Capital Management
New York
$302K -$1.49M -169,454 -82%
EAM
117
Erste Asset Management
Austria
$293K – – –
State Board of Administration of Florida Retirement System
118
State Board of Administration of Florida Retirement System
Florida
$287K -$933K -106,056 -75%
US Bancorp
119
US Bancorp
Minnesota
$286K -$117K -13,282 -27%
Wells Fargo
120
Wells Fargo
California
$283K -$5.97K -679 -2%
BJL
121
Brighton Jones LLC
Washington
$270K +$3.1K +352 +1%
OQS
122
Occudo Quantitative Strategies
Florida
$263K +$48.4K +5,508 +20%
TF
123
TIAA FSB
Florida
$226K – – –
HighTower Advisors
124
HighTower Advisors
Illinois
$226K +$144K +16,419 +144%
CG
125
Caprock Group
Idaho
$225K -$40.3K -4,586 -14%
3 4
5
6 7

ADPT Hedge Fund Activity: Q2 2022 in Review

209 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q2 2022, worth a combined $1.08B — down 38% from $1.74B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of ADPT and 30 opened new positions — a net loss of 10 holders — while 58 trimmed existing stakes and 88 added.

The largest buyer was Blue Water Life Science Advisors, opening a new position worth an estimated $27.4M. The largest seller was Massachusetts Financial Services, cutting an estimated $17.9M.

  • 209 institutional investors held Adaptive Biotechnologies (ADPT) as of Q2 2022, down from 221 in Q1 2022.
  • Funds reported $1.08B of Adaptive Biotechnologies stock for Q2 2022, down 38% quarter-over-quarter.
  • 30 funds opened new Adaptive Biotechnologies positions in Q2 2022 and 40 closed out, a net change of -10 holders.
  • The largest Adaptive Biotechnologies buyer in Q2 2022 was Blue Water Life Science Advisors, an estimated $27.4M added.
  • The largest Adaptive Biotechnologies seller in Q2 2022 was Massachusetts Financial Services, an estimated $17.9M sold.

Based on aggregated 13F filings for Q2 2022.